公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | A novel drug suppresses proliferation of lung cancer cells via increasing the CBL activity and down-regulating epidermal growth factor receptor | Huang, Kuo-Yen; Pan, Szu-Hua; Wang, Wen-Lung; Chen, Ching-Shih; Hong, Tse-Ming; Yang, Pan-Chyr | Cancer Res. | 0 | 0 | |
2023 | Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma | Hong, Xuan; Hsieh, Min-Tsang; Tseng, Tzu-Yu; Lin, Hui-Yi; Chang, Hung-Chih; Yau, Sir-Theng; Cheng, Wei-Chung ; Ke, Baozhen; Liao, Hsiao-Hui; Wu, Chih-Ying; Liu, An-An; Wu, Meei-Maan; Huang, Kuo-Yen; PAN-CHYR YANG ; Kuo, Sheng-Chu; Hung, Mien-Chie; Lee, Pei-Chih | The Journal of biological chemistry | 1 | 0 | |
2019 | Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer | Chen, Zhong; Huang, Kuo-Yen; Ling, Yong; Goto, Masuo; Duan, Hua-Qing; Tong, Xiao-Hang; Liu, Yan-Li; Cheng, Yung-Yi; Morris-Natschke, Susan L; PAN-CHYR YANG ; Yang, Shi-Lin; Lee, Kuo-Hsiung | Journal of natural products | 32 | 29 | |
2021 | Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection | Huang, Kuo-Yen; Lin, Ming-Shiu; Kuo, Ting-Chun; Chen, Ci-Ling; Lin, Chung-Chih; Chou, Yu-Chi; TAI-LING CHAO ; Pang, Yu-Hao; Kao, Han-Chieh; Huang, Rih-Sheng; Lin, Steven; SUI-YUAN CHANG ; PAN-CHYR YANG | EMBO Molecular Medicine | 40 | 32 | |
2021 | Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses | SUI-YUAN CHANG ; Huang, Kuo-Yen; TAI-LING CHAO ; Kao, Han-Chieh; Pang, Yu-Hao; Lu, Lin; Chiu, Chun-Lun; Huang, Hsin-Chang; Cheng, Ting-Jen Rachel; JIM-MIN FANG ; PAN-CHYR YANG | Scientific reports | 29 | 28 | |
2023 | PM2.5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathway | Wang, Tong-Hong; Huang, Kuo-Yen; Chen, Chin-Chuan; Chang, Ya-Hsuan; Chen, Hsuan-Yu; Hsueh, Chuen; Liu, Yi-Tsen; Yang, Shuenn-Chen; PAN-CHYR YANG ; Chen, Chi-Yuan | EMBO molecular medicine | 10 | 7 | |
2022 | A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant | Chang, Yi-Chung; Yang, Chi-Fan; Chen, Yi-Fen; Yang, Chia-Chun; Chou, Yuan-Lin; Chou, Hung-Wen; Chang, Tein-Yao; TAI-LING CHAO ; Hsu, Shu-Chen; Ieong, Si-Man; Tsai, Ya-Min; Liu, Ping-Cheng; Chin, Yuan-Fan; Fang, Jun-Tung; Kao, Han-Chieh; Lu, Hsuan-Ying; Chang, Jia-Yu; Weng, Ren-Shiuan; Tu, Qian-Wen; Chang, Fang-Yu; Huang, Kuo-Yen; Lee, Tong-Young; SUI-YUAN CHANG ; PAN-CHYR YANG | EMBO molecular medicine | 21 | 17 | |
2023 | Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response | Lin, Chia-Yi; Huang, Kuo-Yen; Kao, Shih-Han; Lin, Ming-Shiu; Lin, Chih-Chien; Yang, Shuenn-Chen; Chung, Wei-Chia; Chang, Ya-Hsuan; Chein, Rong-Jie; PAN-CHYR YANG | Science advances | 5 | 3 | |
2022 | Using host receptor as a decoy to treat COVID-19: a solution for immune escape? | Huang, Kuo-Yen; Lin, Ming-Shiu; PAN-CHYR YANG | EMBO molecular medicine | 0 | 0 | |
2021 | Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer | Lin, Chia-Yi; Huang, Kuo-Yen; Lin, Yi-Chun; Yang, Shuenn-Chen; Chung, Wei-Chia; YIH-LEONG CHANG ; JIN-YUAN SHIH ; CHAO-CHI HO ; Lin, Chih-An; Shih, Chih-Chun; Chang, Ya-Hsuan; Kao, Shih-Han; PAN-CHYR YANG | Cancer letters | 19 | 13 | |